Check out our ObamaCare news archive to get the latest news on the Affordable Care Act or to thumb through news articles stretching back to 2012.
There is no Obamacare subsidy cliff for 2025 open enrollment, that means families will not lose out on tax credits simply for making over 400% of the poverty level.
For the 2025 coverage year, Open Enrollment begins on November 1, 2024, and ends on January 15, 2025, in most states. To have coverage that starts on January 1, 2025, you need to enroll by December 15, 2024.
As of December 1, 2023, North Carolina has expanded its Medicaid program to over 600,000 thanks to the Affordable Care Act.
The 2024 open enrollment season, from November 1, 2023, to January 15, 2024, in most states, introduces several updates in the Marketplace, particularly in terms of subsidies.
The Affordable Care Act (ACA) open enrollment for 2024 is here. Running from November 1, 2023, through January 15, 2024, open enrollment allows individuals and families to either sign up for new health insurance plans or make changes to their existing ones.
It’s time for everyone to update their insurance plans The ACA Open Enrollment for 2024 is essential for individuals and families across the United States to re-evaluate their health insurance plans. The Affordable Care Act (ACA) continues to be a cornerstone in availing healthcare coverage to a vast swath of the American populace. As we… Read More
The Surge in Health Insurance Costs: A Comprehensive Analysis Inflation’s Impact on Health Costs: The health insurance landscape is undergoing significant changes. The average cost of workplace health insurance premiums for family coverage has escalated to nearly $24,000 this year. This marks a 7% increase from 2022, as revealed by the latest annual KFF survey… Read More
The ACA and Its Ongoing Legal Battles The Patient Protection and Affordable Care Act, commonly known as the ACA, has been a cornerstone of American healthcare policy for over a decade. Its significance? It aimed to make health care more accessible and affordable for millions of Americans. While the Court did uphold the ACA in… Read More
A New Era in Drug Pricing The Biden administration is on the point of a significant announcement. They are about to reveal the first batch of prescription drugs for which Medicare will negotiate prices. This move has been met with resistance, especially from drugmakers who are not in favor of this change. This initiative is… Read More
Introduction to Medicare Part D Medicare Part D, a program that offers outpatient prescription drug benefits, is a lifeline for older adults and individuals with long-term disabilities. These beneficiaries can enroll in private plans, including stand-alone prescription drug plans (PDPs) and Medicare Advantage prescription drug plans (MA-PDs). These plans supplement traditional Medicare and include drug… Read More
“It is time to call out so-called Medicare Advantage for what it is,” said Rep. Rosa DeLauro. This statement underscores the growing concern among Democratic U.S. lawmakers about Medicare Advantage. This program, essentially private insurance, has been accused of profiting by denying coverage and using the name of Medicare to trick our seniors. On July… Read More
The House Republicans’ CHOICE Act has been making headlines recently, signaling a shift in the political landscape of health insurance. This legislation aims to reduce health insurance costs for specific businesses and consumers, partly by rolling back some consumer protections established under the Affordable Care Act, commonly known as Obamacare. A Subtle Shift from “Repeal… Read More
The Affordable Care Act (ACA) Under Threat The Affordable Care Act (ACA), a landmark health insurance law, has faced numerous challenges since its inception 13 years ago. Today, it finds itself in new jeopardy. The focus this time is on a vital provision of the ACA – the requirement for free coverage of preventive health… Read More
Retirees may need to brace themselves for a potential increase in one of their regular costs — Medicare Part B premiums — in 2024. This projected increase is primarily driven by a new Alzheimer’s treatment recently entering the market. The Projected Increase in Medicare Part B Premiums Earlier this year, the Medicare trustees projected that… Read More
In a significant development, Johnson & Johnson (JNJ.N) has taken legal action against the U.S. government. The healthcare giant seeks to prevent the enforcement of a new program that empowers Medicare to negotiate drug prices. This move makes Johnson & Johnson the latest drugmakers to rally against the policy. The Inflation Reduction Act and Its… Read More
The Inflation Reduction Act’s Medicare drug price negotiation provision is set to revolutionize the affordability and accessibility of medications for millions of Americans. This groundbreaking reform is particularly significant for women, Black, Hispanic or Latino, LGBTQI+, and disabled beneficiaries who have historically faced challenges accessing necessary medications due to high costs. The Inflation Reduction Act:… Read More
The Chamber of Commerce has stepped into the legal limelight. The organization recently filed a preliminary injunction against the Medicare Drug Price Negotiation Program. This move, falling under the auspices of the Inflation Reduction Act, is designed to halt the program’s progression while it is under judicial review. The reason behind this strategic action is… Read More
The Inflation Reduction Act and the Drug Price Negotiation Program Under the Inflation Reduction Act, the federal government is now mandated to negotiate the price of high-spending drugs covered by Medicare Part D, the outpatient prescription drug benefit program, and Medicare Part B. This gave birth to the new Medicare Drug Price Negotiation Program, a… Read More
Chair of the House Energy and Commerce Committee, Cathy McMorris Rodgers (R-WA), and the Chair of the Subcommittee on Health, Brett Guthrie (R-KY), revealed the plans for a subcommittee hearing titled “Innovation Saves Lives: Evaluating Medicare Coverage Pathways for Innovative Drugs, Medical Devices, and Technology.” Medicare’s Evolution: The Chairs’ Vision The Chairs highlighted the urgency… Read More
FDA Approves New Alzheimer’s Treatment The U.S. Food and Drug Administration (FDA) recently approved Biogen and Eisai Co. Ltd.’s Alzheimer’s treatment, Leqembi, also known as lecanemab. This ground-breaking drug is designed to reduce the buildup of amyloid beta plaque in the brain – a hallmark of Alzheimer’s disease. This is a significant step forward, as… Read More
The Medicare Advantage Quality Bonus Program (QBP) was born out of the Affordable Care Act and carried the expectation to revolutionize Medicare Advantage (MA) plans by reducing payments to MA organizations. However, according to the Urban Institute report, the program must still meet these expectations. The report highlights several instances where the QBP is found… Read More
Proposed Medicare cuts pose a significant risk to patients and communities nationwide. Challenges such as workforce shortages, rising costs, and supply chain disruptions have already strained America’s hospitals and health systems. These institutions play a vital role in providing quality and accessible care 24/7, meeting the needs of communities in times of illness and crisis…. Read More
In a groundbreaking move, the U.S. Department of Health and Human Services (HHS) recently announced actions to reduce healthcare costs significantly. This move is part of the implementation of President Biden’s lower-cost prescription drug law – the Inflation Reduction Act (IRA). This law has already started to provide financial relief to covered seniors and people… Read More
Early detection is crucial in a world where cancer remains a leading cause of death. That is the aim of the Multi-Cancer Early Detection Bill, a groundbreaking piece of legislation that can potentially change the landscape of cancer screenings in the United States. The bill, introduced in the Senate, seeks to increase equitable access to… Read More
A Groundbreaking Proposal The Republican Study Committee (RSC), a group that includes 175 GOP members of the U.S. House of Representatives, has recently proposed two substantial changes to Social Security and Medicare as part of their federal budget for the fiscal year 2024. These proposals represent significant shifts in the structure and delivery of these… Read More